Skip to main content

Table 2 Differences in skin rash in Chinese breast cancer patients treated with albumin-bound and conventional paclitaxel

From: Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients

Groups, Regimen

Reference

No. of patients

No rash

Rash

P value

P vaule

P value

P value

Chinese, ABX + DDP

Our data

73

46

27

Ref.*

0.15

<0.0001

-

Chinese, ABX

Guan et al. [21]

104

76

28

0.15

Ref*

<0.0001

-

Chinese, PTX

Guan et al. [21]

106

96

10

<0.0001

0.001

Ref.*

-

Western, PTX

Seidman [22]

49

46

3

-

-

-

Ref.*

Western, ABX

Yamamoto [20]

229

220

9

<0.0001

0.001

-

0.49

  1. *Ref. is the reference of the column. The P value resulted from the comparison of the group and the Ref. group.